Search Results
Feb 05, 2026, 08:00 ET PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026
biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a
More news about: PTC Therapeutics, Inc.
Feb 05, 2026, 08:00 ET Jon-Mikel Bailey Joins Xecunet as Director of Marketing
and reliable communications infrastructure can transform IT from a reactive cost center into a strategic business enabler."Jon-Mikel brings a rare combination of deep marketing leadership and a strong understanding of how technology impacts real business outcomes," said Dallas Kincaid, CEO at Xecunet.
More news about: Xecunet
Feb 05, 2026, 08:00 ET Sparkle Grooming Co. Announces Landmark 67-License Deal Across the Mid-Atlantic and Southeast
required to scale high-performing brands."This is a defining moment for Sparkle," said Joe Aeppli, COO and Co-Founder. "Sanjay brings an incredibly rare combination of institutional-level financial expertise, hands-on understanding of franchising, and a genuine passion for pets and community. As we continue
More news about: Sparkle Grooming Corp.
Feb 05, 2026, 08:00 ET HealthTrackRx Partners with SYNERGEN Health to Bolster Revenue Cycle Operations at Scale
"SYNERGEN has built a team of tenured professionals that offer the rare combination of deep lab revenue cycle expertise and cutting-edge technology, with a culture that truly feels like a partnership where our teams are
More news about: SYNERGEN Health
Feb 05, 2026, 08:00 ET The Rainwater Charitable Foundation Announces 2026 Rainwater Prize Winners, Advancing Research in Primary Tauopathies and Neurodegenerative Disease
(RCF) was created in the early 1990s by Richard E. Rainwater, the late private equity investor and philanthropist. When Richard was diagnosed with a rare neurodegenerative disease and primary tauopathy called Progressive Supranuclear Palsy (PSP), the RCF expanded its mission to accelerate the development
More news about: The Rainwater Charitable Foundation
Feb 05, 2026, 07:46 ET Peabody Reports Results for the Quarter and Year Ended December 31, 2025
tonne benchmark pricing, an increase of more than 30 percent over the estimate of late 2024.Rare Earth Elements and Critical Mineral AdvancementPeabody continues to pursue rare earth element (REE) and critical mineral (CM) opportunities from "unconventional" deposits, with substantial
More news about: Peabody
Feb 05, 2026, 07:30 ET Hyundai Santa Fe Awarded Best Family Car of 2026 by Cars.com
Cars.com. " It's that rare 'tweener' SUV that works just as well for growing families as it does for everyday life, which is why it stood out and was recognized as
More news about: Hyundai Motor America
Feb 05, 2026, 07:20 ET INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
biopharmaceutical company that focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases.The Ultragenyx class action lawsuit alleges that defendants throughout the Class Period made false
More news about: Robbins Geller Rudman & Dowd LLP
Feb 05, 2026, 07:00 ET Bounteous Launches Claude Code Lab Series in Partnership with Anthropic to Accelerate Responsible AI Adoption
ethical, and enterprise-ready," said Martin Young, Executive Vice President of Data & AI at Bounteous. "Through this workshop, we're giving leaders a rare opportunity to work directly with Claude Code and accelerate their readiness for responsible AI adoption."Following years of applied work in
More news about: Bounteous
Feb 05, 2026, 07:00 ET Bounteous Launches Claude Code Lab Series in Partnership with Anthropic to Accelerate Responsible AI Adoption
ethical, and enterprise-ready," said Martin Young, Executive Vice President of Data & AI at Bounteous. "Through this workshop, we're giving leaders a rare opportunity to work directly with Claude Code and accelerate their readiness for responsible AI adoption."Following years of applied work in
More news about: Bounteous
Feb 05, 2026, 06:00 ET The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
formulary management and access to our home delivery pharmacy. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help our clients drive better whole-person
More news about: The Cigna Group
Feb 05, 2026, 04:00 ET Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese project in South Africa
-- Frontier Rare Earths Limited ("Frontier" or the "Company"), which is developing the Zandkopsdrift magnet rare earths and battery grade manganese project in South Africa, is pleased to announce the signing of a Technology Supply Agreement with Carester SAS ("Carester"), one of the leading western rare earths
More news about: Frontier Rare Earths Limited
Feb 05, 2026, 04:00 ET Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese project in South Africa
-- Frontier Rare Earths Limited ("Frontier" or the "Company"), which is developing the Zandkopsdrift magnet rare earths and battery grade manganese project in South Africa, is pleased to announce the signing of a Technology Supply Agreement with Carester SAS ("Carester"), one of the leading western rare earths
More news about: Frontier Rare Earths Limited
Feb 05, 2026, 03:00 ET Reinventing EMS Education: "All Access with Andy Garcia" to Highlight Axene Continuing Education LLC
significantly higher information retention months after the training is completed. Such retention is vital in a field where a paramedic may need to recognize a rare cardiac pattern or administer a complex drug protocol in a matter of seconds. The program examines the role of sensory activation in the learning process,
More news about: All Access
Feb 05, 2026, 03:00 ET BC Platforms partners with OmicsBank to expand access to large-scale real-world and multi-omics data from India and the UAE
catchment outside the United States. Therapeutic area coverage spans oncology, cardiometabolic and cardiovascular diseases, neurology, immunology, and rare diseases, helping to accelerate research and evidence generation across the full drug lifecycle.About BC PlatformsBC Platforms
More news about: BC Platforms
Feb 05, 2026, 02:25 ET Sobi Q4 and FY 2025 report: Closing the year with significant growth and strategic progress
here.Sobi®Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2025, revenue amounted to SEK
More news about: Swedish Orphan Biovitrum AB
Feb 05, 2026, 02:22 ET Sobi Q4 and FY 2025 report: Closing the year with significant growth and strategic progress
here.Sobi®Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2025, revenue amounted to SEK
More news about: Swedish Orphan Biovitrum AB
Feb 04, 2026, 16:53 ET REGAL REXNORD REPORTS STRONG FOURTH QUARTER 2025 FINANCIAL RESULTS, INCLUDING ORGANIC GROWTH ACCELERATION AND DATA CENTER ORDERS WORTH ~$735M
Canada, Mexico, China, and other countries, and retaliatory tariffs and import/export restrictions, including Chinese export restrictions on certain rare earth minerals, or other trade restrictions imposed by the US or other governments; risks associated with global manufacturing, including risks associated
More news about: Regal Rexnord Corporation
Feb 04, 2026, 16:05 ET Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026
of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential
More news about: Viking Therapeutics, Inc.
Feb 04, 2026, 11:30 ET Interlune Announces Details of NASA STTR Project to Advance Scalable, Multipurpose Lunar Trenching and Excavation Technology
excavation. Interlune will initially apply this technology to harvest helium-3 from the Moon, then expand to other resources, including industrial metals, rare Earth elements, and rocket propellants. In addition to harvesting natural resources, Interlune technology is applicable to excavation and construction
More news about: Interlune
Feb 04, 2026, 10:15 ET Bain & Company appoints Jamie Cleghorn to lead its global Customer practice
François Faelli, Global Head of Capabilities at Bain & Company. "Jamie brings a rare combination of strategic rigor, commercial instinct, and technological fluency. He is exceptionally well positioned to build on the practice's strong
More news about: Bain & Company
Feb 04, 2026, 10:00 ET Savor Launches Personal Care & Beauty Division, Bringing Carbon-Based Platform to Cosmetics Industry
luxurious feel and conditioning benefits traditionally sourced from animals in a pure, consistent and radically responsible form. Mimetic features rare, skin-mimicking lipids (molecules that echo the skin's own barrier structure and are abundant in Savor's platform yet scarce in plant oils) to help restore
More news about: Savor
Feb 04, 2026, 09:05 ET Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program
2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its novel oral therapy targeting
More news about: Cumberland Pharmaceuticals Inc.
Feb 04, 2026, 09:00 ET Mezzion Pharmaceuticals Applauds Give Kids a Chance Act Becoming Law
restores the Rare Pediatric Disease Priority Review Voucher (PRV) program and advances reforms designed to support pediatric drug development and accelerate patient access to life-saving therapies."This signing reinforces a national commitment to children and families living with rare diseases,"
More news about: Mezzion Pharmaceuticals, Inc
Feb 04, 2026, 09:00 ET King of Kentucky introduces Small Batch Collection honoring the 250th Anniversary of the United States
the brand since 1936 and revived it in 2018. It has become one of the most sought-after bottles in whiskey."For years, I've held onto these rare, aged barrels, waiting for a moment significant enough to share them," said Chris Morris, Brown-Forman Master Distiller Emeritus. "To celebrate the founding
More news about: King of Kentucky